TrialPLoS medicine2019

Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial.

Piero Ruscitti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.